Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

GSK, along with several other drug manufacturing companies, had received a warning letter from the Federal Trade Commission ...

GlaxoSmithKline Pharmaceuticals and Sasken Technologies have released their financial results for the quarter that ended on ...

The continent is being drenched in an avalanche of medical disinformation with the aim of undermining western influence ...

Boehringer Ingelheim, GSK, Novartis, Teva ... It followed up with a first block of 10 warning letters – aimed at manufacturers of asthma inhalers, epinephrine autoinjectors, and other drug ...

AZ has confirmed that the US regulator issued a complete response letter (CRL) for PT010, a triple therapy for COPD that would compete with GSK’s already-marketed Trelegy. A spokesman for AZ tol ...

Pharmaceutical and agricultural companies are among the industry groups pushing against a proposed levy on their returns from ...

While uncertainty often casts a shadow on the Street, U.S. investors welcomed the presidential and congressional election results with a late-night surge that carried into this morning. The Dow Jones ...

The AFL-CIO, the biggest national unions for teachers, communications workers and government employees co-operated on a ...

Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, ...